Announcements Trials
Browse Landscape

Phase

Phase 1 20Phase 1/2 13Phase EARLY_PHASE1 4Phase NA 3Phase 4 1Phase 2 1

Status

Not yet recruiting 3Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Breast Neoplasms 219Neoplasms 177Lung Neoplasms 92Prostatic Neoplasms 89Colorectal Neoplasms 88Carcinoma, Non-Small-Cell Lung 48Stomach Neoplasms 45Motor Activity 45Carcinoma, Hepatocellular 45Pancreatic Neoplasms 40Uterine Cervical Neoplasms 39Anxiety Disorders 39Rectal Neoplasms 34Head and Neck Neoplasms 31Colonic Neoplasms 30Pain 26Depression 26Brain Neoplasms 25Polycystic Ovary Syndrome 24Esophageal Neoplasms 24Disease 23Multiple Myeloma 22Hematologic Neoplasms 22Endometrial Neoplasms 22Ovarian Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Urinary Bladder Neoplasms 18Pain, Postoperative 18Glioblastoma 18Liver Neoplasms 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Not yet recruiting × Advanced Solid Tumors × Clear all
NCT07534813 2026-04-16

A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors

Grit Biotechnology

Phase NA Not yet recruiting
16 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT07438093 2026-02-27

Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors

The First Affiliated Hospital of Xiamen University

Phase NA Not yet recruiting
60 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06889675 2025-03-21

First in Human Study of YB1-X7 Injection

Shanghai Salvectors Biotechnology LTD.

Phase NA Not yet recruiting
36 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡